Modulation of the N-methyl-D-aspartate receptor by haloperidol: NR2B- specific interactions

Journal of Neurochemistry

Volumn 70, Issue 5, 1998, Pages 2120-2128

  Gallagher, Michael J ^a   Huang, Hui ^a   Lynch, David R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Chimeric receptor; Ifenprodil; Spermidine

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SPERMIDINE;

AMINO ACID SUBSTITUTION; ARTICLE; CHIMERA; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RECEPTOR AFFINITY; SITE DIRECTED MUTAGENESIS;

MURINAE;

EID: 0031959129     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70052120.x     Document Type: Article

References (41)

1. Armenteros J. L., Adams P. B., Campbell M., and Eisenberg Z. W. (1995) Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children. Psychopharmacol. Bull. 31, 363-369.
2. Benveniste M. and Mayer M. L. (1993) Multiple effects of spermine on N-methyl-D-aspartic acid receptor responses of rat cultured hippocampal neurones. J. Physiol. (Lond.) 464, 131-163.
3. Carter C., Benavides J., Legendre P., Vincent J. D., Noel F., Thuret F., Lloyd K. G., Arbilla S., Zivkovic B., MacKenzie E. T., Rousseau J., Scatton B., and Wick A. (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J. Pharmacol Exp. Ther. 247, 1222-1232.
4. Castro R., Brito B., Segovia J., Martin-Trujillo J. M., and Notario V. (1994) Prenatal haloperidol induces a selective reduction in the expression of plasticity-related genes in the neonate forebrain. Brain Res. Mol. Brain Res. 26, 74-80.
5. Chazot P. L., Coleman S. K., Cik M., and Stephenson F. A. (1994) Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J. Biol. Chem. 269, 24403-24409.
6. Chen C. and Okayama H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
7. Chenard B. L., Bordner T. W., Butler L. K., Chambers M. A., Collins D. L., DeCosta M. F., Ducat M. F., Dumont M. L., Fox C. B., Mena E. E., Menniti F. S., Nielsen M. J., Pagnozzi K. E., Richter R. T., Shalaby J. Z., Stemple J. Z., and White W. F. (1995) (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotcctant which blocks N-methyl-D-aspartate responses. J. Med. Chem. 38, 3138-3145.
8. Choi D. W. and Rothman S. M. (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171-182.
9. 3H]-ifenprodil binding in rat brain membranes. J. Pharmacol. Exp. Ther. 280, 584-592.
10. Durand G. M., Gregor P., Zheng X., Bennett M. V., Uhl G. R., and Zukin R. S. (1992) Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc. Natl. Acad. Sci. USA 89, 9359-9363.
11. Durand G. M., Bennett M. V., and Zukin R. S. (1993) Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. Proc. Natl. Acad. Sci. USA 90, 6731-6735.
12. Fagg G. E. (1987) Phencyclidine and related drugs bind to the activated N-methyl-D-aspartate receptor-channel complex in rat brain membranes. Neurosci. Lett. 76, 221-227.
13. Ferrer-Montiel A. V., Sun W., and Montai M. (1995) Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizocilpine. Proc. Natl. Acad. Sci. USA 92, 8021-8025.
14. Fletcher E. J. and MacDonald J. F. (1993) Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. Eur. J. Pharmacol. 235, 291-295.
15. Gallagher M. J., Huang H., Pritchett D. B., and Lynch D. R. (1996) Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 271, 9603-9611.
16. Gallagher M. J., Huang H., and Lynch D. R. (1997) The NR2B specific interactions of polyamines and protons with the N-methyl D-aspartate receptor. J. Biol. Chem. 272, 24971-24979.
17. Hollmann M., Boulter J., Maron C., Beasley L., Sullivan J., Pecht G., and Heinemann S. (1993) Zinc potentiates agonist induced currents at certain splice variants of the NMDA receptor. Neuron 10, 943-954.
18. Ikeda K., Nagasawa M., Mori H., Araki K., Sakimura K., Watanabe M., Inoue Y., and Mishina M. (1992) Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel. FEBS Lett. 313, 34-38.
19. Ilyin V. I., Whittemore E. R., Guastella J., Weber E., and Woodward R. M. (1996) Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol. Pharmacol. 50, 1541-1550.
20. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., Akazawa C., Shigemoto R., Mizuno N., Masu M., and Nakanishi S. (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268, 2836-2843.
21. Javitt D. C. and Zukin R. S. (1991) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148, 1301-1308.
22. Kuryatov A., Laube B., Betz H., and Kuhse J. (1994) Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins. Neuron 12, 1291-1300.
23. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K., Meguro H., Masaki H., Kumanishi T., Arakawa M., and Mishina M. (1992) Molecular diversity of the NMDA receptor channel. Nature 358, 36-41.
24. Lipton S. A. (1993) Prospects for clinically tolerated NMDA antagonists, open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16, 527-532.
25. Lynch D. R. and Gallagher M. J. (1996) Inhibition of N-methyl-D-aspartate receptors by haloperidol. Developmental and pharmacological characterization in native and recombinant receptors. J. Pharmacol. Exp. Ther. 279, 154-161.
26. Lynch D. R., Lawrence J. J., Lenz S., Anegawa N. J., Dichter M., and Pritchett D. B. (1995) Pharmacological characterization of heterodimeric NMDA receptors composed of NR 1 a and 2B subunits: differences with receptors formed from NR1a and 2A. J. Neurochem. 64, 1462-1468.
27. Lynch D. R., Gallagher M. J., Lenz S. J., Anegawa N. J., and Grant E. R. (1996) Pharmacology of recombinant NMDA receptors, in The Ionotropic Glutamate Receptors (Monaghan D. and Wenthold R., eds), pp. 325-347. Humana Press, Totowa, New Jersey.
28. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanishi T., Arakawa M., Sakimura K., and Mishina M. (1992) Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357, 70-74.
29. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomel H., Burnashev N., Sakmann B., and Seeburg P. H. (1992) Heteromeric NMDA receptors, molecular and functional distinction of subtypes. Science 256, 1217-1221.
30. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., and Nakanishi S. (1991) Molecular cloning and characterization of the rat NMDA receptor. Nature 354, 31-37.
31. Nakanishi N., Axel R., and Schneider N. A. (1992) Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA 89, 8552-8556.
32. Pontecorvo M. J., Karbon E. W., Goode S., Clissold D. B., Borosky S. A., Patch R. J., and Ferkany J. W. (1991) Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents. Brain Res. Bull. 26, 461-465.
33. Reynolds I. J. and Miller R. J. (1989) Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines. Mol. Pharmacol. 36, 758-765.
34. Rock D. M. and MacDonald R. L. (1992) Spermine and related polyamines produce a voltage-dependent reduction of N-methyl-D-aspartate receptor single-channel conductance. Mol. Pharmacol. 42, 157-164.
35. Verma A. and Kulkarni S. K. (1992) D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats. Psychopharmacology (Berlin) 109, 477-483.
36. Wafford K. A., Kathoria M., Bain C. J., Marshall G., Le Bourdelles B., Kemp J. A., and Whiting P. J. (1995) Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site. Mol. Pharmacol. 47, 374-380.
37. Williams K. (1993) Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44, 851-859.
38. Williams K. (1995) Modulation of NMDA receptors by polyamines, in Polyamines, Regulation and Molecular Interaction (Casero R. A., ed), pp. 129-170. R. G. Landes Co., Austin, Texas.
39. Williams K., Dawson V. L., Romano C., Dichter M. A., and Molinoff P. B. (1990) Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron 5, 199-208.
40. Williams K., Zappia A. M., Pritchett D. B., Shen Y. M., and Molinoff P. B. (1994) Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol. Pharmacol. 45, 803-809.
41. Zhong J., Russell S. L., Pritchett D. B., Molinoff P. B., and Williams K. (1994) Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol. Pharmacol. 45, 846-853.